Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
DexCom Looks Poised to Correct or Pull Back on Weakening Momentum
12:12pm, Thursday, 30'th Jul 2020
The charts of the maker of medical devices for monitoring diabetes suggest a pause in its shares may be ahead.
DexCom, Inc. Just Beat EPS By 76%: Here's What Analysts Think Will Happen Next
11:42am, Thursday, 30'th Jul 2020
A week ago, DexCom, Inc. (NASDAQ:DXCM) came out with a strong set of quarterly numbers that could potentially lead to...
DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates
01:40pm, Wednesday, 29'th Jul 2020
DexCom's (DXCM) second-quarter results benefit from solid segmental performance.
Does DexCom (NASDAQ:DXCM) Have A Healthy Balance Sheet?
10:55am, Wednesday, 29'th Jul 2020
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
How DexCom More Than Doubled Wall Street's Q2 Earnings Estimate
10:03am, Wednesday, 29'th Jul 2020
DexCom, which makes continuous glucose monitoring (CGM) systems for diabetes management, announced its second-quarter results after the market closed on Tuesday, and there was plenty of good news for
Dexcom Inc (DXCM) Q2 2020 Earnings Call Transcript
05:31am, Wednesday, 29'th Jul 2020
DXCM earnings call for the period ending June 30, 2020.
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q2 2020 Results - Earnings Call Transcript
10:59pm, Tuesday, 28'th Jul 2020
DexCom, Inc. (NASDAQ:DXCM) Q2 2020 Earnings Conference Call July 28, 2020, 04:30 PM ET Company Participants Sean Christensen - Senior Investor Relations Manager Kevin Sayer - Chairman, President and C
DexCom (DXCM) Surpasses Q2 Earnings and Revenue Estimates
09:45pm, Tuesday, 28'th Jul 2020
DexCom (DXCM) delivered earnings and revenue surprises of 154.84% and 11.11%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Dexcom Stock Up, Masimo Stock Slips On Medtech Earnings Beats
08:55pm, Tuesday, 28'th Jul 2020
Medtech companies Masimo and Dexcom late Tuesday reported second-quarter earnings that beat expectations, but only Dexcom stock rose as Masimo declined to provide guidance for the year.
Recap: DexCom Q2 Earnings
08:42pm, Tuesday, 28'th Jul 2020
Shares of DexCom (NASDAQ:DXCM) increased 1% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 887.50% year over year to $0.79, which beat the e
Dexcom : Reports Second Quarter 2020 Financial Results | MarketScreener
08:04pm, Tuesday, 28'th Jul 2020Dexcom Reports Second Quarter 2020 Financial Results
08:03pm, Tuesday, 28'th Jul 2020
Dexcom Reports Second Quarter 2020 Financial Results
Charting a (bullish) holding pattern, S&P 500 digests break to 5-month highs
04:44pm, Tuesday, 28'th Jul 2020
The major U.S. benchmarks are acting well technically, though amid increasingly sideways late-July price action, writes Michael Ashbaugh.
DexCom, Inc. 2020 Q2 - Results - Earnings Call Presentation
04:20pm, Tuesday, 28'th Jul 2020
The following slide deck was published by DexCom, Inc. in conjunction with their 2020 Q2 earnings call..
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
